Published in Gene Therapy Weekly, April 6th, 2000
"Because of a critical shortage in suitable organs, many patients with terminal liver disease die each year before liver transplantation can be performed," explained N. Kobayashi and colleagues at Okayama University in Japan ("Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes," Science, 2000;287(5456):1258-1262).
Some researchers have suggested transplanting isolated hepatocytes to stabilize these patients; however, according to Kobayashi et al., there is currently no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.